Alkermes Completes Acquisition of Rodin Therapeutics

Acquisition Expands Alkermes' Research and Development Efforts to Include Small Molecule Therapeutics for Synaptopathies DUBLIN, Nov. 25, 2019 -- (Healthcare Sales & Marketing Network) -- Alkermes plc (Nasdaq: ALKS) today announced that it has complete... Biopharmaceuticals, Neurology, Mergers & Acquisitions Alkermes, Rodin Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news